Pharma giant overcomes patent expiry of arthritis blockbuster Remicade and fallingmedical device sales
Company known as Merck in North America is to build a second manufacturing facility
Deal to acquire maker emergency of overdose treatment Narcan worth €549 million
Drugmaker has already spent £40m stockpiling medicines in Britain and Europe
Former Ardagh CEO Ian Curley to become executive chairman on an interim basis
Drug targets tumour cells, leading to fewer side effects
Company racked up losses despite income rising 3% to €429m
Sitryx’s co-founders include Luke O’Neill, prof of biochemistry at Trinity college
Shareholders opposed plans to move the company’s HQ to the Netherlands
After several false starts, way is clear for John Thero to take Vascepa cholesterol drug to market
Health Innovation Hub Ireland aims to strengthen collaboration between Irish companies and the public health sector
Pharmaceutical sector urges faster access to markets and sharper focus on innovation
Ex-chief of innovative health unit Bourla to assume control as Read becomes executive chairman
Firm will use funds to expand team, fund patient trials and get regulatory approval
Irish pharma research company completes €10m investment into facility expansion
Company, whose backers include Oyster Capital and Elkstone, has FDA clearance
Amyrt’s EB development asset progressing through phase three clinical trial
Clinical trials group falls to a loss but is optimistic for the future
23 trophies were presented to winning companies at a gala award ceremony held in the Clayton Hotel in Dublin on the 5th of October
Invalid email or password.
![John Thero: “We’re taking the approach of make it [Vascepa] affordable, and hopefully we can help millions of patients and make some money along the way”](/polopoly_fs/1.3651727.1538671571!/image/image.jpg_gen/derivatives/box_300_160/image.jpg "John Thero: “We’re taking the approach of make it [Vascepa] affordable, and hopefully we can help millions of patients and make some money along the way”")
